C4 Therapeutics - Ownership and Business Overview

Life ScienceCompany

C4 Therapeutics Ownership

Who owns C4 Therapeutics?

.

Was C4 Therapeutics formerly PE-backed?

Yes. C4 Therapeutics was formerly owned by 1 private investor.

C4 Therapeutics Business Overview

Where is C4 Therapeutics headquartered?

C4 Therapeutics is headquartered in Watertown, Massachusetts.

What is C4 Therapeutics’ revenue?

C4 Therapeutics disclosed revenue of 21M USD for 2023 and 31M USD for 2022.

How many employees does C4 Therapeutics have?

C4 Therapeutics has 145 employees.

What sector is C4 Therapeutics in?

C4 Therapeutics is a life science company.

When was C4 Therapeutics founded?

C4 Therapeutics was founded in 2015.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

C4 Therapeutics

C4 Therapeutics, Inc.

490 Arsenal Way, Suite 120,
Watertown, Massachusetts 02472
United States,
(617) 231-0700
www.c4therapeutics.com

C4 Therapeutics is a biopharmaceutical company that develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma, peripheral T-cell lymphoma, and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid malignancies; and BRAF V600E and RET programs for genetically defined resistant solid tumors. It has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. C4 Therapeutics was founded in 2015 and is based in Watertown, Massachusetts.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.